NO990792L - FremgangsmÕte for inhibering av ekspresjonen av FAS - Google Patents

FremgangsmÕte for inhibering av ekspresjonen av FAS

Info

Publication number
NO990792L
NO990792L NO990792A NO990792A NO990792L NO 990792 L NO990792 L NO 990792L NO 990792 A NO990792 A NO 990792A NO 990792 A NO990792 A NO 990792A NO 990792 L NO990792 L NO 990792L
Authority
NO
Norway
Prior art keywords
fas
inhibiting
expression
Prior art date
Application number
NO990792A
Other languages
English (en)
Other versions
NO990792D0 (no
Inventor
Giora Zeev Feuerstein
Tian-Li Yue
Original Assignee
Boehringer Mannheim Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Pharm Corp filed Critical Boehringer Mannheim Pharm Corp
Publication of NO990792D0 publication Critical patent/NO990792D0/no
Publication of NO990792L publication Critical patent/NO990792L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO990792A 1996-08-23 1999-02-19 FremgangsmÕte for inhibering av ekspresjonen av FAS NO990792L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2448696P 1996-08-23 1996-08-23
PCT/US1997/014792 WO1998007321A1 (en) 1996-08-23 1997-08-22 Method for inhibiting the expression of fas

Publications (2)

Publication Number Publication Date
NO990792D0 NO990792D0 (no) 1999-02-19
NO990792L true NO990792L (no) 1999-04-15

Family

ID=21820837

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990792A NO990792L (no) 1996-08-23 1999-02-19 FremgangsmÕte for inhibering av ekspresjonen av FAS

Country Status (17)

Country Link
US (1) US6096777A (no)
EP (1) EP0924985A4 (no)
JP (1) JP2001504804A (no)
KR (1) KR20000068322A (no)
CN (1) CN1233150A (no)
AU (1) AU4083097A (no)
BR (1) BR9711228A (no)
CA (1) CA2264178A1 (no)
CZ (1) CZ59199A3 (no)
HU (1) HUP9904243A3 (no)
IL (1) IL128613A (no)
NO (1) NO990792L (no)
NZ (1) NZ334307A (no)
PL (1) PL331766A1 (no)
TR (1) TR199900370T2 (no)
WO (1) WO1998007321A1 (no)
ZA (1) ZA977565B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2183870C2 (ru) * 2001-06-26 2002-06-20 Байков Юрий Александрович Устройство для защиты от излучения радиотелефонной трубки
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
CA2483054A1 (en) * 2002-04-30 2003-11-13 Sb Pharmco Puerto Rico Inc. Carvedilol monocitrate monohydrate
KR20110134952A (ko) * 2002-06-27 2011-12-15 스미스클라인 비이참 (코르크) 리미티드 카베딜롤 인산염 및(또는) 그의 용매화물, 상응하는 조성물, 및(또는) 치료 방법
JP2005533822A (ja) * 2002-06-27 2005-11-10 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド 臭化水素酸カルベジロール
US6632832B1 (en) 2002-09-10 2003-10-14 Dabur Research Foundation Anti-cancer activity of carvedilol and its isomers
WO2004024145A1 (en) * 2002-09-10 2004-03-25 Dabur Research Foundation Anti-cancer activity of carvedilol and its isomers
EP1686967A4 (en) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
US7750036B2 (en) * 2003-11-25 2010-07-06 Sb Pharmco Puerto Rico Inc. Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
EP1691789B1 (en) * 2003-11-25 2017-12-20 SmithKline Beecham (Cork) Limited Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
JP2009511562A (ja) * 2005-10-13 2009-03-19 オーキッド リサーチ ラボラトリーズ リミティド pSTAT3/IL−6インヒビターとしての新規ヘテロ環式化合物
JP2012051804A (ja) * 2008-12-26 2012-03-15 Kyoto Univ Eg5阻害剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5393772A (en) * 1993-11-24 1995-02-28 Boehringer Mannheim Pharmaceuticals Corporation Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation

Also Published As

Publication number Publication date
IL128613A0 (en) 2000-01-31
ZA977565B (en) 1999-02-17
US6096777A (en) 2000-08-01
JP2001504804A (ja) 2001-04-10
PL331766A1 (en) 1999-08-02
CN1233150A (zh) 1999-10-27
NZ334307A (en) 2000-11-24
CA2264178A1 (en) 1998-02-26
BR9711228A (pt) 2000-01-11
EP0924985A1 (en) 1999-06-30
EP0924985A4 (en) 2000-12-06
IL128613A (en) 2004-07-25
AU4083097A (en) 1998-03-06
HUP9904243A3 (en) 2001-09-28
TR199900370T2 (xx) 1999-05-21
WO1998007321A1 (en) 1998-02-26
CZ59199A3 (cs) 1999-08-11
HUP9904243A2 (hu) 2000-05-28
NO990792D0 (no) 1999-02-19
KR20000068322A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
NO983405L (no) Fremgangsmåte for ökning av smöreevnen til snöskigrunnflater
FI965268A0 (fi) Menetelmä moniarvoisten alkoholien valmistamiseksi
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
ID20637A (id) Metode untuk menghambat pembentukan sulfida biogenik
FI950800L (fi) Menetelmä heterosyklisten yhdisteiden sulfinyloimiseksi
NO990792D0 (no) FremgangsmÕte for inhibering av ekspresjonen av FAS
FI973095A0 (fi) Menetelmiä ympäristöestrogeenien estämiseksi
ID18300A (id) Metoda penemperan
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
IS4285A (is) Aðferð við að hindra útfellingu
FI971675L (fi) Menetelmä bradykiniinin liittyvien tilojen inhiboimiseksi
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
FI955110A7 (fi) Menetelmä massan sakeuden lisäämiseksi
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler
UA25365A (uk) Спосіб профілактики вториhhої катаракти
FI953181A0 (fi) Puriinien valmistusmenetelmä
HK1020839A (en) Method for inhibiting the expression of fas
UA25398A (uk) Спосіб комбіhоваhої холецистолітотомії
UA25135A (uk) Спосіб гастроєюhопластики
UA25353A (uk) Спосіб холецистостомії
UA25653A (uk) Спосіб проведеhhя скальптерапії
FI963726A0 (fi) Foerfarande foer anordnande av en transaktionsbaserad faktvering i samband med telefontjaenster
SE9300381D0 (sv) Foerfaringssaett vid desinficering av vatten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application